A JAMA Cardiology study led by UT Southwestern shows an AI‑augmented ECG screened nearly 6,000 Kenyans and reliably ruled out left‑ventricular dysfunction for most patients.

Dexcom’s investor day laid out product and reimbursement milestones that local analysts say could channel roughly $800M into San Diego through 2030. The plan hinges on G8 performance, Medicare coverage and broader adoption.

Philanthropist Lynde B. Uihlein gave $10 million to UWM's School of Freshwater Sciences to fund research, water policy and upkeep for research vessels.

UH researchers helped lead a team that identified blood‑based RNA markers for inflammatory breast cancer, pointing to less invasive diagnosis and monitoring. The study appears in Science Advances.

A UC Berkeley working paper ties a post‑ChatGPT surge in A grades to students’ use of generative AI. Campuses are redesigning exams and reinstating proctoring to protect degree value.

Martha Stewart has co‑founded Hint, a Charlotte AI home‑management startup that raised $10M and plans a summer launch to help homeowners spot problems early.

New York’s cannabis regulator has launched a pilot observational study testing oral THC and CBD for adults with inflammatory bowel disease, partnering with licensed dispensaries.

Schwab says AI is boosting efficiency, but surging accounts and assets have the firm adding staff in Texas and at its Westlake campus.

Biogen will advance diranersen — an antisense tau drug given intrathecally — to late‑stage trials after a Phase 2 readout showed tau reduction and hints of slowed decline.

OpenAI is weighing legal steps against Apple after reporting says its ChatGPT tie‑in with Siri hasn’t delivered as promised.

CREATE Medicines, cofounded by Siddhartha Mukherjee, closed a $122M Series B to advance in‑vivo CAR‑T candidates for cancer and autoimmune disease.

A PLOS ONE study traced a 2020 apartment outbreak to shared bathroom ducts and urges retrofits — exhaust fans and non‑return flaps — to reduce airborne spread.

El Paso Children’s Hospital added a Lumenis UltraPulse CO2 laser and a ZEISS KINEVO 900 S microscope to expand burn, scar and complex-surgery care closer to home. Hospital officials say the upgrades will keep more specialty treatment in the Borderland.